135 related articles for article (PubMed ID: 8450453)
1. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
2. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
6. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
7. Are glycineB sites involved in the development of morphine tolerance?
Kotlińska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
8. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal.
Rasmussen K; Brodsky M; Inturrisi CE
Synapse; 1995 May; 20(1):68-74. PubMed ID: 7624831
[TBL] [Abstract][Full Text] [Related]
9. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat.
Dunbar SA; Yaksh TL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1219-25. PubMed ID: 9190856
[TBL] [Abstract][Full Text] [Related]
10. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
11. Purinergic P2X receptor regulates N-methyl-D-aspartate receptor expression and synaptic excitatory amino acid concentration in morphine-tolerant rats.
Tai YH; Cheng PY; Tsai RY; Chen YF; Wong CS
Anesthesiology; 2010 Nov; 113(5):1163-75. PubMed ID: 20938337
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
[TBL] [Abstract][Full Text] [Related]
13. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
15. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice.
Pol O; Puig MM
Br J Pharmacol; 1997 Nov; 122(6):1216-22. PubMed ID: 9401789
[TBL] [Abstract][Full Text] [Related]
16. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
Zhu H; Brodsky M; Gorman AL; Inturrisi CE
Brain Res Mol Brain Res; 2003 Jun; 114(2):154-62. PubMed ID: 12829326
[TBL] [Abstract][Full Text] [Related]
17. N-Methyl-D-aspartate receptor antagonist MK-801 attenuates morphine tolerance and associated glial fibrillary acid protein up-regulation: a proteomic approach.
Wen ZH; Wu GJ; Hsu LC; Chen WF; Chen JY; Shui HA; Chou AK; Wong CS
Acta Anaesthesiol Scand; 2008 Apr; 52(4):499-508. PubMed ID: 18339156
[TBL] [Abstract][Full Text] [Related]
18. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.
Kest B; Mogil JS; Shamgar BE; Kao B; Liebeskind JC; Marek P
Proc West Pharmacol Soc; 1993; 36():307-10. PubMed ID: 8378393
[No Abstract] [Full Text] [Related]
19. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
20. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Davis AM; Inturrisi CE
J Pharmacol Exp Ther; 1999 May; 289(2):1048-53. PubMed ID: 10215686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]